Metal-based nanomaterials for laser desorption/ionization mass spectrometry: A frontier for detecting small-molecule biomarkers in coronary artery disease and heart failure
Shanghai Jiao Tong University Journal CenterObjective: Cardiovascular diseases (CVDs), particularly coronary artery disease (CAD) and heart failure (HF), are leading causes of global mortality. Small-molecule metabolites serve as promising biomarkers for CAD and HF management, yet their low abundance in complex biological matrices poses significant detection challenges. Laser desorption/ionization mass spectrometry (LDI-MS) is a powerful analytical tool, but conventional organic matrices suffer from strong background interference and poor reproducibility. This review systematically summarizes recent advances in metal-based nanomaterials as alternative LDI-MS matrices for small-molecule biomarker detection in CAD and HF, focusing on composition and structural design strategies.
Methods: The authors reviewed and classified metal-based nanomaterials by composition (single-component systems including noble metals and metal oxides; multi-component systems including noble metal-based, metal oxide-based, and MOF-based composites) and structural design (size/morphology control, porous, core-shell, and other structures). Enhancement mechanisms and analytical performance were analyzed, and clinical applications in CAD (stable CAD, acute coronary syndrome, and myocardial infarction) and HF were reviewed.
Results: Compositional engineering enables synergistic effects including localized surface plasmon resonance, enhanced photothermal conversion, efficient charge transfer, and selective analyte enrichment. Structural design optimizes electromagnetic field distribution and provides abundant active sites. In clinical applications, nanomaterial-assisted LDI-MS combined with machine learning achieves excellent diagnostic performance for CAD and HF, including stable CAD screening, ACS subtyping, MI classification, and HF differentiation.
Conclusions: Metal-based nanomaterials significantly enhance LDI-MS performance for metabolite detection through rational design. The technology shows promise for cardiovascular metabolic profiling, but challenges remain regarding fundamental mechanisms, complex synthesis, and clinical translation. Standardized protocols, multicenter validation, and interdisciplinary collaboration are needed to advance clinical implementation.
- Journal
- LabMed Discovery